rs71508957

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2

The NM_032776.3(JMJD1C):​c.7591G>A​(p.Glu2531Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00696 in 1,603,916 control chromosomes in the GnomAD database, including 61 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. E2531E) has been classified as Benign.

Frequency

Genomes: 𝑓 0.0047 ( 6 hom., cov: 32)
Exomes 𝑓: 0.0072 ( 55 hom. )

Consequence

JMJD1C
NM_032776.3 missense

Scores

8
10

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 2.64

Publications

19 publications found
Variant links:
Genes affected
JMJD1C (HGNC:12313): (jumonji domain containing 1C) The protein encoded by this gene interacts with thyroid hormone receptors and contains a jumonji domain. It is a candidate histone demethylase and is thought to be a coactivator for key transcription factors. It plays a role in the DNA-damage response pathway by demethylating the mediator of DNA damage checkpoint 1 (MDC1) protein, and is required for the survival of acute myeloid leukemia. Mutations in this gene are associated with Rett syndrome and intellectual disability. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2015]
JMJD1C Gene-Disease associations (from GenCC):
  • 22q11.2 deletion syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • complex neurodevelopmental disorder
    Inheritance: AD Classification: LIMITED Submitted by: Illumina
  • neurodevelopmental disorder
    Inheritance: AD Classification: LIMITED Submitted by: G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.004607469).
BP6
Variant 10-63168077-C-T is Benign according to our data. Variant chr10-63168077-C-T is described in ClinVar as Likely_benign. ClinVar VariationId is 460278.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High AC in GnomAd4 at 714 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
JMJD1CNM_032776.3 linkc.7591G>A p.Glu2531Lys missense_variant Exon 26 of 26 ENST00000399262.7 NP_116165.1 Q15652-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
JMJD1CENST00000399262.7 linkc.7591G>A p.Glu2531Lys missense_variant Exon 26 of 26 5 NM_032776.3 ENSP00000382204.2 Q15652-1
JMJD1CENST00000542921.5 linkc.7045G>A p.Glu2349Lys missense_variant Exon 25 of 25 1 ENSP00000444682.1 Q15652-3
JMJD1CENST00000402544.5 linkn.7282G>A non_coding_transcript_exon_variant Exon 22 of 22 1
JMJD1CENST00000467356.5 linkn.449G>A non_coding_transcript_exon_variant Exon 3 of 3 1

Frequencies

GnomAD3 genomes
AF:
0.00470
AC:
715
AN:
152116
Hom.:
6
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00154
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00328
Gnomad ASJ
AF:
0.00144
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00331
Gnomad FIN
AF:
0.000660
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.00824
Gnomad OTH
AF:
0.00575
GnomAD2 exomes
AF:
0.00421
AC:
1047
AN:
248660
AF XY:
0.00435
show subpopulations
Gnomad AFR exome
AF:
0.00155
Gnomad AMR exome
AF:
0.00241
Gnomad ASJ exome
AF:
0.000895
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00165
Gnomad NFE exome
AF:
0.00676
Gnomad OTH exome
AF:
0.00696
GnomAD4 exome
AF:
0.00720
AC:
10445
AN:
1451682
Hom.:
55
Cov.:
28
AF XY:
0.00699
AC XY:
5055
AN XY:
722820
show subpopulations
African (AFR)
AF:
0.00132
AC:
44
AN:
33308
American (AMR)
AF:
0.00253
AC:
113
AN:
44698
Ashkenazi Jewish (ASJ)
AF:
0.00111
AC:
29
AN:
26040
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39584
South Asian (SAS)
AF:
0.00291
AC:
250
AN:
86002
European-Finnish (FIN)
AF:
0.00150
AC:
79
AN:
52788
Middle Eastern (MID)
AF:
0.00418
AC:
24
AN:
5748
European-Non Finnish (NFE)
AF:
0.00860
AC:
9492
AN:
1103470
Other (OTH)
AF:
0.00689
AC:
414
AN:
60044
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.467
Heterozygous variant carriers
0
425
851
1276
1702
2127
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
372
744
1116
1488
1860
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00469
AC:
714
AN:
152234
Hom.:
6
Cov.:
32
AF XY:
0.00417
AC XY:
310
AN XY:
74428
show subpopulations
African (AFR)
AF:
0.00154
AC:
64
AN:
41562
American (AMR)
AF:
0.00327
AC:
50
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.00144
AC:
5
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5176
South Asian (SAS)
AF:
0.00331
AC:
16
AN:
4830
European-Finnish (FIN)
AF:
0.000660
AC:
7
AN:
10602
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.00822
AC:
559
AN:
67994
Other (OTH)
AF:
0.00569
AC:
12
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
42
83
125
166
208
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00616
Hom.:
17
Bravo
AF:
0.00488
TwinsUK
AF:
0.00863
AC:
32
ALSPAC
AF:
0.00934
AC:
36
ESP6500AA
AF:
0.00161
AC:
6
ESP6500EA
AF:
0.0100
AC:
82
ExAC
AF:
0.00411
AC:
496
Asia WGS
AF:
0.000867
AC:
3
AN:
3476
EpiCase
AF:
0.00710
EpiControl
AF:
0.00682

ClinVar

Significance: Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jun 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

JMJD1C: BS2 -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

JMJD1C-related disorder Benign:1
May 21, 2019
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Early myoclonic encephalopathy Benign:1
Jan 23, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.14
BayesDel_addAF
Benign
-0.30
T
BayesDel_noAF
Benign
-0.20
CADD
Uncertain
24
DANN
Uncertain
1.0
DEOGEN2
Benign
0.034
.;T;.
Eigen
Uncertain
0.31
Eigen_PC
Uncertain
0.40
FATHMM_MKL
Uncertain
0.93
D
LIST_S2
Uncertain
0.94
D;D;D
MetaRNN
Benign
0.0046
T;T;T
MetaSVM
Benign
-0.49
T
MutationAssessor
Benign
1.4
.;L;.
PhyloP100
2.6
PrimateAI
Uncertain
0.59
T
PROVEAN
Uncertain
-2.5
.;D;N
REVEL
Benign
0.17
Sift
Benign
0.044
.;D;T
Sift4G
Uncertain
0.042
.;D;D
Polyphen
1.0
.;D;.
Vest4
0.63, 0.61
MVP
0.65
MPC
2.0
ClinPred
0.018
T
GERP RS
5.4
Varity_R
0.30
gMVP
0.22
Mutation Taster
=91/9
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs71508957; hg19: chr10-64927837; COSMIC: COSV101232265; API